Jera Lewis

Title: Jera Lewis: Innovator in Cancer Treatment

Introduction

Jera Lewis is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on immunomodulatory therapies, which are crucial for improving patient outcomes in cancer care.

Latest Patents

Jera Lewis holds a patent titled "Methods of determining patient populations amenable to immunomodulatory treatment of cancer." This patent provides methods for identifying patient populations that are suitable for immunomodulatory treatment by measuring the levels of T-cell sub-populations correlated with cancer. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Lewis is affiliated with the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (DHHS). His work at NIH allows him to collaborate with leading experts in the field and contribute to groundbreaking research that has the potential to change the landscape of cancer treatment.

Collaborations

Throughout his career, Jera Lewis has worked alongside esteemed colleagues, including Lawrence Fong and Serena Kwek MacPhee. Their collaborative efforts aim to enhance the understanding and treatment of cancer through innovative research and development.

Conclusion

Jera Lewis is a pioneering inventor whose work in immunomodulatory treatment for cancer exemplifies the intersection of innovation and healthcare. His contributions are vital for the future of cancer therapies, and his ongoing research promises to improve patient care significantly.